P38 Mapk Inhibition
P38 Mapk Inhibition - Related Videos
01:07
MAPK Signaling Cascades
0 Views •
2023
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
00:46
Feedback Inhibition
0 Views •
2019
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell! Since enzymes help control the rate of reactions, their activity is regulated so that appropriate amounts of starting materials, intermediate metabolites, and products are maintained in the cell. Excessive build-up or depletion of...
01:30
Enzyme Inhibition
0 Views •
2025
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure. Competitive inhibitors occupy the active site of enzymes, making them unable to accommodate the substrate. However, sufficiently high...
02:29
Measuring Immune-Induced Inhibition of Seedling Growth
0 Views •
2025
This video demonstrates the seedling growth inhibition assay in the Arabidopsis thaliana plant. The impact of increased concentration of immune peptide elicitor on seedling growth is determined.
07:59
Temporal Quantification of MAPK Induced Expression in Single Yeast Cells
0 Views •
Cited by 6 •
2013
Two complementary methods based on flow cytometry and microscopy are presented which enable the quantification, at the single cell level, of the dynamics of gene expression induced by the activation of a MAPK pathway in yeast.
FAQs
An inhibitor may act at the p38 kinase itself or interfere with its upstream activation. These strategies both reduce signaling, but they can differ in how broadly they affect pathway behavior because upstream control occurs before kinase activity, whereas kinase blockade acts closer to downstream phosphorylation events. This distinction helps researchers interpret pathway-specific effects in immune and stress-response studies.
Downstream phosphorylation shows whether pathway signaling has been functionally reduced, rather than merely indicating that an inhibitor was present. Measuring this event alongside inflammatory mediators can connect pathway activity with biological outcomes, including cytokine and chemokine production. The combined information helps determine whether altered immune responses reflect effective signaling suppression.
The outcome depends on the balance between limiting damaging inflammation and preserving protective host defense. Reduced signaling may decrease inflammatory activity and tissue injury, but excessive pathway suppression could affect leukocyte activation or pathogen control because p38 participates in innate immune responses. Infection models therefore need to assess both inflammatory effects and host responses to microbial challenge.
Researchers can examine whether reduced pathway activity lowers cytokine or chemokine production while preserving, weakening, or otherwise changing responses to microbial challenge. Comparing these outcomes clarifies whether p38 signaling mainly contributes to inflammatory tissue injury in a given setting or also supports useful innate immune activity. This distinction is central when considering anti-inflammatory intervention during infection.
A conceptual workflow begins by applying pathway inhibition in an immune or infection-related system, then determining whether p38 signaling and downstream phosphorylation are reduced. Investigators can measure inflammatory cytokines and chemokines, examine leukocyte activation or tissue injury, and include microbial challenge when relevant. Interpreting these measurements together links molecular pathway modulation with host-level outcomes.
Useful outcomes span several biological levels: reduced phosphorylation of downstream targets indicates pathway engagement, while cytokine and chemokine measurements show inflammatory mediator production. Leukocyte activation and tissue injury provide additional immunological consequences, and responses to microbial challenge reveal effects on host defense and pathogen control. Using multiple outcome types prevents conclusions based on a single signaling or inflammation marker.
The approach is useful when researchers need to test whether changing p38 signaling can reduce inflammatory mediators, leukocyte activation, or tissue injury in a defined immune or infection context. It also reveals potential tradeoffs involving innate immunity and pathogen control. Consequently, pathway inhibition can support therapy evaluation while identifying whether dampening inflammation may compromise protective host responses.